← SynDRA
BAY1436032
SynDRA canonical compound SYN0039319 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | IDH1 |
|---|
| Mechanism of action | isocitrate dehydrogenase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- IDH1 INHIBITOR
- Isocitrate dehydrogenase [NADP] cytoplasmic inhibitor
- isocitrate dehydrogenase inhibitor
Cross-references
Synonyms
- RNMAUIMMNAHKQR-QFBILLFUSA-N
- BAY 1436032
- SCHEMBL17009632
- EX-A1606
- AKOS032946249
- SB19763
- HY-100020
- CS-0017982
- 3-(2-((4-(trifluoromethoxy)phenyl)amino)-1-((1R,5R)-3,3,5-trimethylcyclohexyl)-1H-benzo[d]imidazol-5-yl)propanoic acid
- RefChem:116744
- Pan-Mutant-IDH1 Inhibitor Bay-1436032
- orb1296249
- SCHEMBL30192044
- C26H30F3N3O3
- BDBM404661
- GLXC-15293
- HMS6018E18
- DXC27465
- MFCD30533279
- NSC794487
- s8530
- NSC-794487
- US10344004, Test compound Table 3
- AC-36182
- DA-61515
- MS-29100
- G15940
- BAY-1436032; BAY 1436032; BAY1436032
Look up BAY1436032 in the interactive SynDRA portal →